Search results
FDA lifts hold on Larimar's Friedreich's Ataxia drug study By Investing.com
Investing.com· 6 days agoThe FDA's decision followed a review of Phase 2 data, which included a four-week, placebo-controlled...
ENDRA meets with FDA on liver device clinical trial design By Investing.com
Investing.com· 7 days agoFood and Drug Administration (FDA) regarding its TAEUS liver device. The meeting, which took place...
Achilles Therapeutics and Arcturus team up for cancer vaccine By Investing.com
Investing.com· 5 days agoAchilles Therapeutics plc (NASDAQ: ACHL), a biopharmaceutical company specializing in T cell...
Why government regulation isn’t a clear cut issue in tech anymore
Fortune· 3 days agoMany founders and investors sound like broken records as they grouse about the heavy hand of government regulation. After writing a series of articles about the hidden ties between TikTok and ...
FDA greenlights SAB Biotherapeutics' diabetes drug trial By Investing.com
Investing.com· 6 days agoThe U.S. Food and Drug Administration (FDA) has cleared SAB Biotherapeutics' investigational new...
Sustainability in healthcare is a team sport: Providers and vendors must work together
Becker’s Hospital Review· 5 days agoSustainability is a high-priority issue for hospital and health system leaders. A hospital patient in the United States generates approximately 33.8 pounds of waste per day ...
ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM)...
Digital Journal· 3 days agoORLANDO, FL / ACCESSWIRE / May 24, 2024 / RedChip Companies will air interviews with ASP Isotopes Inc. (Nasdaq:ASPI) and Calidi Biotherapeutics Inc. (NYSE American:CLDI) on the RedChip Small ...
Coya Therapeutics completes Phase 2 Alzheimer's study By Investing.com
Investing.com· 5 days agoCoya Therapeutics, Inc. (NASDAQ: COYA), a biotech firm focusing on treatments to enhance regulatory...
Piper Sandler upbeat on Alpha Tau Medical stock, cits cash burn By Investing.com
Investing.com· 6 days agoOn Tuesday, Piper Sandler reiterated its Overweight rating on Alpha Tau Medical Ltd. (NASDAQ:DRTS)...
Piper Sandler bulish on NovoCure stock, cites advancing cancer treatments By Investing.com
Investing.com· 3 days agoOn Friday, Piper Sandler reaffirmed its Overweight rating on NovoCure Ltd. (NASDAQ:NVCR) stock with...